The largest database of trusted experimental protocols

3 protocols using recombinant human heregulin β1

1

Evaluation of ErbB2/HER2 Biosimilar Candidates

Check if the same lab product or an alternative is used in the 5 most similar protocols
The reference products in this study were selected randomly from 154 lots of EU- and US-sourced reference product. The CellTiter-Blue® and CytoTox-Glo® kits were obtained from Promega (Madison, WI, USA). The phycoerythrin (PE) anti-human CD340 (ErbB2/HER2) antibody was obtained from Biolegend (San Diego, CA, USA). The ErbB2/HER2 enzyme-linked immunosorbent assay (ELISA) kit was obtained from R&D Systems (Minneapolis, MN, USA), the Phospho-Akt (Ser473) ELISA kit was obtained from Cell Signaling Technology (Danvers, MA, USA), and the Human VEGF Quantikine® ELISA kit was obtained from R&D Systems. The CellTrace™ carboxyfluorescein succinimidyl ester (CFSE) Cell Proliferation Kit was obtained from Thermo Fisher Scientific (Waltham, MA, USA), the docetaxel (Taxotere®) was obtained from Sanofi-Aventis (Paris, France), and the PathHunters® Flash Detection Kit was obtained from DiscoverX (Fremont, CA, USA). The recombinant human heregulin-β1 was obtained from Peprotech (Seoul, South Korea) and the Caspase-glo 3/7 assay kit was obtained from Promega.
+ Open protocol
+ Expand
2

Differentiation of T-MSCs into Schwann Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To differentiate T-MSCs into SCs, we used the technique of Razavi et al. [41 (link)] in which human T-MSCs were induced to form neurospheres. We harvested human T-MSCs (80%–90% confluence) and then plated them in plastic dishes at (1.5–2) × 105 cells/cm2 in DMEM/F-12 (Welgene Inc., Daegu, Korea) supplemented with 20 ng/mL basic fibroblast growth factor (bFGF, PeproTech, London, UK), 20 ng/mL epidermal growth factor (EGF, PeproTech), and 2% B27 supplement (1:50, Gibco, Life Technologies, Burlington, ON, Canada) at 37 °C under 5% CO2 in humidified air. We replenished the cultures with fresh medium every 3–4 days. After 7 days, neurospheres were triturated using a 25-gauge needle and replated in laminin-coated cell culture plates containing DMEM/F12 supplemented with 10% FBS, 14 µM forskolin (Sigma-Aldrich), 5 ng/mL platelet-derived growth factor-AA (PDGF, PeproTech), 10 ng/mL bFGF (PeproTech) and 200 ng/mL recombinant human heregulin-β1 (PeproTech) for terminal differentiation. The cells were incubated for 9 days under these conditions, and then harvested for further investigations.
+ Open protocol
+ Expand
3

Transdifferentiation of Rat ADSCs into Schwann-Like Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
ADSCs of Sprague-Dawley rats were purchased from Cyagen Biosciences Inc. (RASMD-01001, Santa Clara, CA, USA). The ADSCs were positive for CD29, CD44 and CD90, but negative for CD34 and CD45. The fourth passage culture of ADSCs was used in this study. For transdifferentiation into Schwann-like cells (Kingham et al., 2007), sub-confluent ADSCs at passage 4 were cultured in serum-free ADSCs growth medium that was supplemented with 1 mM β-mercaptoethanol (Sigma-Aldrich) for 24 hours. After washing with phosphate-buffered saline (PBS; 10 mM, pH 7.4), the cells were incubated in ADSC growth medium containing 35 ng/mL all-trans-retinoic acid (Sigma-Aldrich) for 72 hours. The cells were then washed three times in PBS and incubated in ADSC growth medium. This contained 14 μM forskolin (Sigma-Aldrich), 5 ng/mL platelet-derived growth factor-AA (PeproTech, Rocky Hill, NJ, USA), 10 ng/mL basic fibroblast growth factor (PeproTech) and 200 ng/mL recombinant human heregulin-β1 (PeproTech) for 14 days. The medium was replaced every 3 days.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!